The original discovery of BCL7A in a Burkitt lymphoma cell line suggested a potential interaction with actin, which would be a novel unexplored SWI/SNF mechanism as the BCL7 proteins bind to the HSA domain, which was previously described as an actin-related binding protein domain (Zani et al, 1996; Szerlong et al, 2008). Here, BCL7A is linked to Burkitt lymphoma.